CDC NORTH AFRICA HEALTHCARE LIMITED
Get an alert when CDC NORTH AFRICA HEALTHCARE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-04 (in 6mo)
Last made up 2025-10-21
Watchouts
None on the register
Cash
£3M
+191.1% vs 2023
Net assets
£53M
+3.5% vs 2023
Employees
0
Average over period
Profit before tax
£2M
+68.4% vs 2023
Net assets
2-year trend · vs Financials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | £11,585,299 | £21,758,566 | |
| Profit before tax | £1,133,605 | £1,908,941 | |
| Net profit | £1,015,941 | £1,779,982 | |
| Cash | £931,638 | £2,711,634 | |
| Total assets less current liabilities | £51,061,997 | £52,841,979 | |
| Net assets | £51,061,997 | £52,841,979 | |
| Equity | £51,061,997 | £52,841,979 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | 22.7% | 41.2% | |
| Gearing (liabilities / total assets) | 0.2% | 0.2% | |
| Current ratio | 14.73x | 26.63x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“With support from British International Investment plc ("BII"), the Directors have a reasonable expectation that the Company will have adequate financial resources to continue in operational existence for at least the next 12 months. BII has issued a letter of support which confirms that BII will cover any ongoing expenses incurred by the Company and the Company has adequate cash and cash equivalents driven by investment income. Whilst the letter of support is not a legal contract, the Directors have full confidence that BII will continue to support the Company. In assessing the going concern status for the Company, the Directors have closely monitored the Company's investment portfolio throughout the year and has considered the cash flow forecasts of the intermediate parent company, BII. Current forecasts demonstrate that BII and its subsidiaries (the "Group") have sufficient liquid resources available to maintain planned investment pace for at least 12 months from the date of issue of the financial statements without needing to draw on the revolving credit facility. Having performed the assessment on going concern, the Directors consider it appropriate to prepare the financial statements of the Company on a going concern basis. The Directors consider the Company has adequate financial resources and liquidity and is well placed to manage business risks in the current economic environment to continue operations for a period of at least 12 months from the date of issue of the financial statements.”
Group structure
- CDC NORTH AFRICA HEALTHCARE LIMITED · parent
- Alfa Laboratories Egypt 19.7%
- Alfa Scan 19.7%
- El Safa for Medical Services 19.31%
Significant events
- “The tariffs recently announced by the US have caused market volatility on a global scale and are expected to have a significant impact on the geographies in which the Group invests. The tariffs are likely to introduce volatility to markets and uncertainty over valuations. The quantum of the effect on the Company is difficult to determine at this time. Investee companies may also face liquidity issues that could impact their operations and ability to repay debt. We have considered the impact of the ongoing uncertainty in forming our conclusion that the entity remains a going concern and are comfortable this continues to be the case on the basis of the nature of the entity's payables, stable expense base, positive cash position and letter of support.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| PURKIS, Matthew James | Secretary | 2020-10-02 | — | — |
| ROWLANDS, Simon Nicholas | Director | 2023-04-03 | Jun 1957 | British |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| EARL, Jane | Secretary | 2019-12-19 | 2020-10-02 |
| PARVIEZ, Shazia | Secretary | 2019-10-22 | 2019-12-19 |
| COLES, Christopher James Mckenzie | Director | 2019-10-22 | 2020-11-16 |
| CORCORAN, Michael John | Director | 2019-10-29 | 2020-07-31 |
| CUCCIOLI, Leandro German | Director | 2023-04-03 | 2024-05-22 |
| EARL, Jane | Director | 2019-10-22 | 2023-04-04 |
| MORGAN, Anthony David | Director | 2020-11-16 | 2024-01-23 |
| OSBORNE, David Delano Franklin | Director | 2019-10-29 | 2020-11-16 |
| SIMS, Carolyn | Director | 2020-10-02 | 2026-04-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| British International Investment Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-10-22 | Active |
Filing timeline
Last 20 of 37 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-12 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-06 | AA | accounts | Accounts with accounts type full | |
| 2024-11-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-24 | AA | accounts | Accounts with accounts type full | |
| 2024-05-24 | TM01 | officers | Termination director company with name termination date | |
| 2024-01-25 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-06 | AA | accounts | Accounts with accounts type small | |
| 2023-04-20 | AP01 | officers | Appoint person director company with name date | |
| 2023-04-14 | AP01 | officers | Appoint person director company with name date | |
| 2023-04-14 | TM01 | officers | Termination director company with name termination date | |
| 2022-10-26 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-07-13 | AA | accounts | Accounts with accounts type full | |
| 2022-05-04 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2021-10-29 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-07-22 | AA | accounts | Accounts with accounts type full | |
| 2021-03-25 | SH01 | capital | Capital allotment shares | |
| 2021-03-24 | SH01 | capital | Capital allotment shares | |
| 2021-01-11 | SH14 | capital | Capital redomination of shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
+191.1%
£931,638 £2,711,634
-
Net assets
+3.5%
£51,061,997 £52,841,979
-
Employees
—
Not reported
-
Operating profit
+87.8%
£11,585,299 £21,758,566
-
Profit before tax
+68.4%
£1,133,605 £1,908,941
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers